San Francisco startup Structure Therapeutics can be focusing on an oral, as soon as-each day GLP-one drug known as GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June whenever a mid-stage analyze showed regular weight loss of all around 6% and it options to start out One more mid-phase trial towards the top of this 12 months—that